Work

The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug development.

Year: 2003

Type: article

Source: PubMed

Authors: P A Patten, H Schellekens

Institution: Maxygen (United States)

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2414521524

FWCI: 1.557

Cites:

Cited by: 59

Related to: 10